These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2469280)

  • 61. [Comparative study of the multiplication rate and oxidation-reduction activity of Shigella flexneri hybrids with different characteristics].
    Petrovskaia VG; Smirnov SG; Blinova NI; Smirnov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Jan; 48(1):5-10. PubMed ID: 4928701
    [No Abstract]   [Full Text] [Related]  

  • 62. On the drug-resistance of enteric bacteria. 6. Spontaneous and artificial elimination of transmissible drug-resistance factors.
    MITSUHASHI S; HARADA K; KAMEDA M
    Jpn J Exp Med; 1961 Apr; 31():119-23. PubMed ID: 13771420
    [No Abstract]   [Full Text] [Related]  

  • 63. Effects of aquatic environmental stress on enteric bacterial pathogens.
    McFeters GA; Singh A
    Soc Appl Bacteriol Symp Ser; 1991; 20():115S-120S. PubMed ID: 1887264
    [No Abstract]   [Full Text] [Related]  

  • 64. [Characteristics of Escherichia serogroup O132:K isolated in intestinal diseases in monkeys].
    Shurgaia MA
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):39-43. PubMed ID: 6760629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Escherichia coli-Shigella hybrids and their pathogenicity for mucous membranes].
    STENZEL W
    Z Hyg Infektionskr; 1961; 147():521-8. PubMed ID: 13916844
    [No Abstract]   [Full Text] [Related]  

  • 66. Utilization of sodium acetate by Shigella and Escherichia.
    Costin ID
    J Gen Microbiol; 1965 Oct; 41(1):23-7. PubMed ID: 5327584
    [No Abstract]   [Full Text] [Related]  

  • 67. Inhibition of Shigella flexneri by the normal intestinal flora. II. Mechanisms of inhibition by coliform organisms.
    Hentges DJ
    J Bacteriol; 1969 Feb; 97(2):513-7. PubMed ID: 4886281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IMPLANTATION ANTAGONISM BETWEEN E. COLI AND NON-PATHOGENIC OR FACULTATIVELY PATHOGENIC ENTERIC BACTERIA.
    KETYI I
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():225-36. PubMed ID: 14270398
    [No Abstract]   [Full Text] [Related]  

  • 69. The evolution of invasion by enteric bacteria.
    Ochman H; Groisman EA
    Can J Microbiol; 1995 Jul; 41(7):555-61. PubMed ID: 7641138
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Possible effects of foreign DNA on pathogenic potential and intestinal proliferation of Escherichia coli.
    Freter R
    J Infect Dis; 1978 May; 137(5):624-9. PubMed ID: 351075
    [No Abstract]   [Full Text] [Related]  

  • 71. Plasmids and the virulence of enteric and other bacterial pathogens.
    Kopecko DJ; Formal SB
    Ann Intern Med; 1984 Aug; 101(2):260-2. PubMed ID: 6378008
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of changes in Mg++ ion concentration upon bacterial inhibition by beta-2-thienylalanine in defined media.
    Brown KJ; Lines DR
    Aust J Exp Biol Med Sci; 1978 Aug; 56(4):507-11. PubMed ID: 365154
    [TBL] [Abstract][Full Text] [Related]  

  • 73. On the drug-resistance of enteric bacteria. 3. Transmission of the drug-resistance from Shigella to F--or Hfr strains of E.coli K-12.
    MITSUHASHI S; HARADA K; KAMEDA M; SUZUKI M; EGAWA R
    Jpn J Exp Med; 1960 Aug; 30():301-6. PubMed ID: 13771418
    [No Abstract]   [Full Text] [Related]  

  • 74. The Sixth John M. Kinney-Nestlé Clinical Nutrition Award for Enteral Nutrition. Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucin glycoprotein, and the HT29-C1 intestinal cell line: a context.
    Wanke CA
    Nutrition; 1999 Jun; 15(6):427-9. PubMed ID: 10378192
    [No Abstract]   [Full Text] [Related]  

  • 75. The virulence-enhancing factor of mucins. 3. further fractionation of hog gastric mucin; an additional factor in the adjuvant action.
    SMITH H
    Biochem J; 1951 Apr; 48(4):441-7. PubMed ID: 14838864
    [No Abstract]   [Full Text] [Related]  

  • 76. Distribution of an inducible hexose-phosphate transport system among various bacteria.
    Winkler HH
    J Bacteriol; 1973 Nov; 116(2):1079-81. PubMed ID: 4583235
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Models to study enteropathogenic bacteria: lessons learned from Shigella.
    Siebers A; Finlay BB
    Trends Microbiol; 1995 Jun; 3(6):207-9. PubMed ID: 7648027
    [No Abstract]   [Full Text] [Related]  

  • 78. Shigella and Salmonella: death as a means of survival.
    Haimovich B; Venkatesan MM
    Microbes Infect; 2006 Feb; 8(2):568-77. PubMed ID: 16297650
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Geographical structure and host specificity in bacteria and the implications for tracing the source of coliform contamination.
    Gordon DM
    Microbiology (Reading); 2001 May; 147(Pt 5):1079-1085. PubMed ID: 11320111
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibition of Shigella flexneri by the normal intestinal flora. I. Mechanisms of inhibition by Klebsiella.
    Hentges DJ
    J Bacteriol; 1967 Apr; 93(4):1369-73. PubMed ID: 6032512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.